Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
Clinical trial NCT05044039 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05044039
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2026-01-06
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.